Detalhe da pesquisa
1.
Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER.
Ther Innov Regul Sci
; 57(3): 436-444, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459346
2.
Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
Oncologist
; 15(12): 1344-51, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148614
3.
Sorafenib for the treatment of unresectable hepatocellular carcinoma.
Oncologist
; 14(1): 95-100, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19144678
4.
On Bayesian Analysis and Hypothesis Testing in the Determination of Bioequivalence.
Clin Pharmacol Ther
; 105(2): 304-306, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666636
5.
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer.
Clin Cancer Res
; 19(18): 4911-6, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23801166
6.
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary.
Clin Cancer Res
; 18(14): 3722-30, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22665903
7.
Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood.
J Theor Biol
; 236(3): 242-55, 2005 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-15916772